NEW YORK (
CHANGE IN RATINGS
(AEO - Get Report) was upgraded at Wedbush from Neutral to Outperform. $22 price target. Positive store checks suggest that higher sales and margins are around the corner, Wedbush said.
(AH) was downgraded at UBS to Neutral from Hold. $11 price target. Possibly more issues lurking around the corner, UBS said.
(ALR - Get Report) was upgraded at Leerink Swann to Outperform from Market Perform. $28-$30 valuation range. Attractive upside potential, Leerink Swann said.
Abercrombie & Fitch
(ANF - Get Report)
was upgraded to Buy from Neutral at UBS. $66 price target. Trend stabilization and favorable risk/reward, UBS said.
was upgraded at Piper Jaffray from Neutral to Overweight. $32 price target. Company is posting higher sales growth, Piper Jaffray said.
was upgraded at Mizuho from Neutral to Buy. $35 price target. Business fundamentals are improving, Mizuho said.
(COST - Get Report)
was downgraded at Deutsche Bank to Hold. Valuation call, based on an $89 price target, Deutsche Bank said.
was initiated with a Buy rating at Canaccord Genuity. $32 price target. Company has a broad product portfolio that addresses a big market opportunity, Canaccord said.
was upgraded at Morgan Stanley from Underweight to Equal-Weight. Visibility is improving and the Pall purchase can drive long-term growth, Morgan Stanley said.
(HOLX - Get Report)
was downgraded at Dougherty to Neutral. $20 price target. GPRO acquisition is unimpressive, Dougherty said.
was downgraded at Auriga USA from Buy to Hold. Valuation call, based on a $98 price target, Auriga USA said.
was initiated with a Hold rating at Keybanc. Company lacks near-term catalysts, Keybanc said.
was initiated with a Neutral rating at Goldman Sachs. Valuation call, based on a $23 price target.
Vantiv was initiated with a Buy rating at Deutsche Bank. $26 price target. New merchant wins are driving organic growth, Deutsche Bank said.
was upgraded at Credit Suisse from Neutral to Outperform. $27 price target. Estimates also boosted, as management is turning the business around, Credit Suisse said.
STOCK COMMENTS / EPS CHANGES
Bed Bath & Beyond
numbers raised at Oppenheimer. Shares are now seen reaching $84. Estimates were also raised on sales and margin momentum, Oppenheimer said. Outperform rating.